https://it.marketscreener.com/quotazioni/azione/INTRON-BIOTECHNOLOGY-INC-20706294/attualita/INtRON-Biotechnology-Inc-Conferma-l-efficacia-di-BAL200-una-nuova-endolisina-biologica-per-l-antr-42835287/?utm_source=telegram&utm_medium=social&utm_campaign=share